Zydus Lifesciences Archives

Zydus Lifesciences Board Approves Rs 84 Crore Acquisition of Sterling Biotech API Business; Shares Trading Flat

Esha SomadderSeptember 17, 2024September 17, 2024

by Esha SomadderSeptember 17, 2024September 17, 202411508

Shares of Zydus Lifesciences Ltd. are trading flat after reaching a day’s high of Rs 1,125 on 17th September, following the board’s approval of the...

MARKETS

Zydus Lifesciences Ltd Q1 Report; Profit Rise 2-Folds; Shares Slump 2%

Ali WaghbakriwalaAugust 11, 2023August 11, 2023

by Ali WaghbakriwalaAugust 11, 2023August 11, 202307121

Shares of Zydus Lifesciences Ltd on Friday, 11 August, were trading in the red even after the company reported a two-fold rise in consolidated net...

MARKETS

Anupam Rasayan, Zee and Zydus Lifesciences Among Top Stocks to Watch Today

Chinmay BohraJune 14, 2023June 14, 2023

by Chinmay BohraJune 14, 2023June 14, 202301912

The domestic equity indices ended the last trading on a high. BSE Sensex ended 418 points higher, while Nifty gained 114 points. Today, both indices...

BUSINESS

Zydus Lifesciences Gets USFDA Approval for Smoking Addiction Treating Drug

Chinmay BohraJune 13, 2023June 13, 2023

by Chinmay BohraJune 13, 2023June 13, 202302156

Ahmedabad-headquartered pharmaceutical company Zydus Lifesciences announced on Tuesday that it has received approval for manufacturing and marketing a generic version of Varenicline tablets from the...

MARKETS

Zydus Lifesciences Share Hits 52-Week High on USFDA Approval for Osteoporosis Drug

NileshApril 19, 2023April 19, 2023

by NileshApril 19, 2023April 19, 202301629

Shares of Zydus Lifesciences hit a 52-week high in morning trade on April 19 after the company said it had received final approval from the...

MARKETS

Zydus Lifesciences Shares Rise After USFDA Approves Tofacitinib Tablets

NileshMarch 22, 2023March 22, 2023

by NileshMarch 22, 2023March 22, 202302166

Shares of Zydus Lifesciences were trading in the early hours of March 22, after the company’s subsidiary received USFDA approval for tofacitinib tablets. Zydus Pharmaceuticals...

MARKETS

Back-to-Back USFDA Approvals Boost Zydus Lifesciences, Shares Hit 8-Month High

NileshOctober 10, 2022

by NileshOctober 10, 202201759

Zydus Lifesciences’ drug hit an eight-month high following a string of US regulatory approvals. The stock hit Rs 426 on the NSE on October 7...

BUSINESS

Zydus Lifesciences’ Generic Drug Mirabegron for Overactive Bladder Gets USFDA Nod

Aniruddh ShrivastavaOctober 3, 2022October 3, 2022

by Aniruddh ShrivastavaOctober 3, 2022October 3, 202201331

On Monday, Zydus Lifesciences said it received the USFDA’s (United States Food and Drug Administration) final nod to market its version of Mirabegron extended-release tablets...

HEALTHCARE

Zydus Receives USFDA Approval for Generic Antacid

NileshJune 6, 2022June 6, 2022

by NileshJune 6, 2022June 6, 202201176

On Monday, Zydus Lifesciences said that it had received final approval from US health regulators to market its antacid famotidine tablets in the US market....

BUSINESS HEALTHCARE

Zydus Publishes Phase-3 Clinical Trial Data of ZyCoV-D

NileshApril 1, 2022April 1, 2022

by NileshApril 1, 2022April 1, 202201701

Zydus Lifesciences announced that the safety and efficacy analysis data from the phase-III clinical trial of its Covid-19 vaccine ZyCoV-D has been examined and published...

Download Unicorn Signals App

EquityPandit

Tag : Zydus Lifesciences

Zydus Lifesciences Board Approves Rs 84 Crore Acquisition of Sterling Biotech API Business; Shares Trading Flat

Zydus Lifesciences Ltd Q1 Report; Profit Rise 2-Folds; Shares Slump 2%

Anupam Rasayan, Zee and Zydus Lifesciences Among Top Stocks to Watch Today

Zydus Lifesciences Gets USFDA Approval for Smoking Addiction Treating Drug

Zydus Lifesciences Share Hits 52-Week High on USFDA Approval for Osteoporosis Drug

Zydus Lifesciences Shares Rise After USFDA Approves Tofacitinib Tablets

Back-to-Back USFDA Approvals Boost Zydus Lifesciences, Shares Hit 8-Month High

Zydus Lifesciences’ Generic Drug Mirabegron for Overactive Bladder Gets USFDA Nod

Zydus Receives USFDA Approval for Generic Antacid

Zydus Publishes Phase-3 Clinical Trial Data of ZyCoV-D

EquityPandit